Prospera Financial Services Inc boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 264.6% during the 3rd quarter, Holdings Channel reports. The fund owned 17,238 shares of the medical equipment provider’s stock after buying an additional 12,510 shares during the period. Prospera Financial Services Inc’s holdings in Intuitive Surgical were worth $8,468,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in ISRG. Creekmur Asset Management LLC raised its holdings in Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $26,000. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. LRI Investments LLC purchased a new stake in Intuitive Surgical during the first quarter valued at approximately $30,000. Finally, LGT Financial Advisors LLC boosted its stake in Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 54 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Stock Up 0.8 %
Shares of ISRG opened at $531.64 on Tuesday. The company has a market capitalization of $189.36 billion, a price-to-earnings ratio of 85.47, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $544.38. The stock’s 50-day moving average price is $500.33 and its 200-day moving average price is $459.58.
Wall Street Analyst Weigh In
A number of equities analysts have recently issued reports on the company. Raymond James upped their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Stifel Nicolaus upped their price objective on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. Finally, Citigroup lifted their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $524.61.
Read Our Latest Stock Analysis on ISRG
Insider Buying and Selling
In related news, insider Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the transaction, the insider now owns 8,757 shares in the company, valued at $4,727,816.73. The trade was a 2.98 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amy L. Ladd sold 450 shares of the stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the transaction, the director now owns 821 shares in the company, valued at $402,519.88. This represents a 35.41 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 91,178 shares of company stock valued at $45,897,071. Corporate insiders own 0.80% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- Top Biotech Stocks: Exploring Innovation Opportunities
- Instacart: Is it Time to Back Up the Cart on the Stock?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Insiders Selling Into 3 Rallies: Investors Should Do the Opposite
- P/E Ratio Calculation: How to Assess Stocks
- 3 Under-the-Radar Oil Stocks to Keep Your Eye On
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.